Single-agent irinotecan as second-line treatment for advanced gastric cancer

---

Kanat O., Evrensel T., Manavoglu O., Demiray M., Kurt E., Gonullu G., ...Daha Fazla

TUMORI JOURNAL, cilt.89, sa.4, ss.405-407, 2003 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 89 Sayı: 4
• Basım Tarihi: 2003
• Doi Numarası: 10.1177/030089160308900411
• Dergi Adı: TUMORI JOURNAL
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.405-407
• Anahtar Kelimeler: gastric cancer, irinotecan, second-line chemotherapy, SUPPORTIVE CARE, PHASE-II, METHOTREXATE, CARBOPLATIN, PACLITAXEL, CISPLATIN
• Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aim: To investigate the activity and toxicity of irinotecan (CPT-11) as a single agent in patients with advanced gastric cancer after failure of previous 5-fluorouracil-based combination chemotherapy.